These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8633399)

  • 21. Biological variation of total, free and percent free serum prostate specific antigen levels in screening volunteers.
    Ornstein DK; Smith DS; Rao GS; Basler JW; Ratliff TL; Catalona WJ
    J Urol; 1997 Jun; 157(6):2179-82. PubMed ID: 9146610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of Tandem-R PSA and Markit-M PA in the diagnosis of prostate cancer].
    Okegawa T; Kato M; Miyata A; Murata A; Miura I; Yoneda T; Nutahara K; Higashihara E
    Hinyokika Kiyo; 1999 Mar; 45(3):175-8. PubMed ID: 10331169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-related reference ranges for complexed prostate-specific antigen and complexed/total prostate-specific antigen ratio: results from East Texas Medical Center Cancer Institute screening campaign.
    Cheli CD; Levine RL; Cambetas DR; Kolker JD; Roberts SB
    Urology; 2002 Oct; 60(4 Suppl 1):53-9. PubMed ID: 12384164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Normal range prostate-specific antigen versus age-specific prostate-specific antigen in screening prostate adenocarcinoma.
    el-Galley RE; Petros JA; Sanders WH; Keane TE; Galloway NT; Cooner WH; Graham SD
    Urology; 1995 Aug; 46(2):200-4. PubMed ID: 7542822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraindividual variations of total and percent free serum prostatic-specific antigen levels in patients with normal digital rectal examination.
    Morote J; Raventós CX; Lorente JA; Enbabo G; López M; de Torres I
    Eur Urol; 1999 Aug; 36(2):111-5. PubMed ID: 10420031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variability of repeated serum prostate-specific antigen (PSA) measurements within less than 90 days in a well-defined patient population.
    Roehrborn CG; Pickens GJ; Carmody T
    Urology; 1996 Jan; 47(1):59-66. PubMed ID: 8560664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum prostate-specific antigen in healthy Chinese men: establishment of age-specific reference ranges.
    Lin WY; Gu CJ; Kao CH; Changlai SP; Wang SJ
    Neoplasma; 1996; 43(2):103-5. PubMed ID: 8843971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ethnic differences in the age-related distribution of serum prostate-specific antigen values: a study in a healthy Korean male population.
    Lee SE; Kwak C; Park MS; Lee CH; Kang W; Oh SJ
    Urology; 2000 Dec; 56(6):1007-10. PubMed ID: 11113748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of the ratio free/total prostate-specific antigen in addition to total PSA levels in prostate cancer screening.
    Reissigl A; Klocker H; Pointner J; Fink K; Horninger W; Ennemoser O; Strasser H; Colleselli K; Höltl L; Bartsch G
    Urology; 1996 Dec; 48(6A Suppl):62-6. PubMed ID: 8973702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.
    Schröder FH; van der Maas P; Beemsterboer P; Kruger AB; Hoedemaeker R; Rietbergen J; Kranse R
    J Natl Cancer Inst; 1998 Dec; 90(23):1817-23. PubMed ID: 9839522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An analytical comparison of the three most commonly used prostate-specific antigen assays: Tandem-R, Tandem-E, and IMx.
    Oesterling JE; Moyad MA; Wright GL; Beck GR
    Urology; 1995 Oct; 46(4):524-32. PubMed ID: 7571222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate-specific antigen and digital rectal examination in screening for prostate cancer: a community-based study.
    Bretton PR
    South Med J; 1994 Jul; 87(7):720-3. PubMed ID: 7517580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long term follow-up of mass screening for prostate carcinoma in men with initial prostate specific antigen levels of 4.0 ng/ml or less.
    Ito K; Kubota Y; Yamamoto T; Suzuki K; Fukabori Y; Kurokawa K; Yamanaka H
    Cancer; 2001 Feb; 91(4):744-51. PubMed ID: 11241242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.
    Uzzo RG; Pinover WH; Horwitz EM; Parlanti A; Mazzoni S; Raysor S; Mirchandani I; Greenberg RE; Pollack A; Hanks GE; Watkins-Bruner D
    Urology; 2003 Apr; 61(4):754-9. PubMed ID: 12670560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population-based screening for prostate cancer by measuring total serum prostate-specific antigen in Iran.
    Hosseini SY; Moharramzadeh M; Ghadian AR; Hooshyar H; Lashay AR; Safarinejad MR
    Int J Urol; 2007 May; 14(5):406-11. PubMed ID: 17511722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microparticle immunoenzymatic assay for detection of prostate specific antigen: characterization of the technique and comparative analysis with a monoclonal immunoradiometric assay.
    Sánchez de la Muela P; Povo Castilla J; Bobillo de Lamo M; Rosales F; Pérez-Piqueras JL
    Mil Med; 1995 Aug; 160(8):416-9. PubMed ID: 8524470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pitfalls in interpreting prostate specific antigen velocity.
    Kadmon D; Weinberg AD; Williams RH; Pavlik VN; Cooper P; Migliore PJ
    J Urol; 1996 May; 155(5):1655-7. PubMed ID: 8627846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate specific antigen variation in patients without clinically evident prostate cancer.
    Lujan M; Paez A; Sanchez E; Herrero A; Martin E; Berenguer A
    J Urol; 1999 Oct; 162(4):1311-3. PubMed ID: 10492186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuations.
    Eastham JA; Riedel E; Scardino PT; Shike M; Fleisher M; Schatzkin A; Lanza E; Latkany L; Begg CB;
    JAMA; 2003 May; 289(20):2695-700. PubMed ID: 12771116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
    Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
    BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.